Literature DB >> 20198328

Development of an oral cancer recurrence mouse model after surgical resection.

Andreas Behren1, York Kamenisch, Sabrina Muehlen, Christa Flechtenmacher, Uwe Haberkorn, Hermann Hilber, Jeffrey N Myers, Zazie Bergmann, Peter Karl Plinkert, Christian Simon.   

Abstract

Oral squamous cell carcinomas (OSCC) are frequent epithelial malignancies and afflicted with a poor prognosis. The majority of these cancers are treated with surgical resection and local recurrences are predominantly responsible for a fatal outcome. In order to provide a better understanding of the development of these local recurrences after surgical ablation, we developed an orthotopic floor-of-mouth squamous cell carcinoma murine model, in which local recurrences occur at a high frequency (55%, 8 out of 15 mice) within 6-21 days after microsurgical removal of the primary. Expression of the enhanced green fluorescent protein (eGFP) in the cancer cells allows in this new model to confirm complete surgical resection under the microscope and helps to track repopulating primary tumor cells in the local recurrence by optical imaging. In addition the model resembles all typical features of invasive head and neck cancers including the formation of lymph node metastasis and local infiltration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198328     DOI: 10.3892/ijo_00000562

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Submaxillary gland androgen-regulated protein 3A expression is an unfavorable risk factor for the survival of oropharyngeal squamous cell carcinoma patients after surgery.

Authors:  Jennifer Koffler; Dana Holzinger; Gustavo Acuña Sanhueza; Christa Flechtenmacher; Karim Zaoui; Bernd Lahrmann; Niels Grabe; Peter K Plinkert; Jochen Hess
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-05       Impact factor: 2.503

Review 2.  Trends in Surgical Research in Head and Neck Cancer.

Authors:  Genrich Tolstonog; Christian Simon
Journal:  Curr Treat Options Oncol       Date:  2017-06

3.  Opposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells.

Authors:  Gustavo A Acuña Sanhueza; Leonie Faller; Babitha George; Jennifer Koffler; Vinko Misetic; Christa Flechtenmacher; Gerhard Dyckhoff; Peter P Plinkert; Peter Angel; Christian Simon; Jochen Hess
Journal:  BMC Cancer       Date:  2012-02-17       Impact factor: 4.430

4.  Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.

Authors:  Rachel A O'Keefe; Neil E Bhola; David S Lee; Daniel E Johnson; Jennifer R Grandis
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

5.  Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model.

Authors:  Sonia Domingos-Pereira; Vincent Roh; Agnès Hiou-Feige; Gabriele Galliverti; Christian Simon; Genrich V Tolstonog; Denise Nardelli-Haefliger
Journal:  Oncoimmunology       Date:  2021-04-13       Impact factor: 8.110

Review 6.  Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma.

Authors:  Qiang Li; Heng Dong; Guangwen Yang; Yuxian Song; Yongbin Mou; Yanhong Ni
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.